Value of intrathecal baclofen in management of severe tetanus in developing countries;Place du baclofene intrathecal dans le traitement du tetanos grave en milieu tropical

Medecine Tropicale

Volumn 60, Issue 4, 2000, Pages 385-388

  Engrand, N ^a  

^a NONE

Author keywords

Baclofen; Black Africa; Burkina Faso; Muscle relaxants; Tetanus

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; BACLOFEN; CENTRAL MUSCLE RELAXANT;

ADULT; ARTICLE; BURKINA FASO; COST BENEFIT ANALYSIS; DEVELOPING COUNTRY; ECONOMICS; ENDOTRACHEAL INTUBATION; HOSPITALIZATION; HUMAN; INTRASPINAL DRUG ADMINISTRATION; PATIENT SELECTION; TETANUS; TREATMENT OUTCOME; TROPICAL MEDICINE;

ADULT; BACLOFEN; BURKINA FASO; COST-BENEFIT ANALYSIS; DEVELOPING COUNTRIES; GABA AGONISTS; HUMANS; INJECTIONS, SPINAL; INTUBATION, INTRATRACHEAL; MUSCLE RELAXANTS, CENTRAL; PATIENT SELECTION; SEVERITY OF ILLNESS INDEX; TETANUS; TREATMENT OUTCOME; TROPICAL MEDICINE;

EID: 0034570655     PISSN: 0025682X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. - REBIERE I. - Le tétanos en France en 1997. Bulletin Epidémiologique Annuel n°2, France, 1997. BEH 1999; N° Spécial : 77-79.
2. - MULLER H., BORNER U., ZIERSKI J., HEMPELMANN G. -Intrathecal baclofen in tetanus. Lancet 1986 ; 1 : 317-318.